Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer

Clinical screening using the National Comprehensive Cancer Network (NCCN) testing criteria may fail to identify all patients with hereditary breast and ovarian cancers. Thus, this study aimed to evaluate the strategy of expanding target patients for genetic testing among Japanese patients. We review...

Descripción completa

Detalles Bibliográficos
Autores principales: Haneda, Eri, Sato, Ann, Suganuma, Nobuyasu, Sebata, Yoshiko, Okamoto, Saki, Toda, Soji, Kohagura, Kaori, Matsubara, Yuka, Sugawara, Yuko, Yamanaka, Takashi, Yamashita, Toshinari, Shimizu, Satoru, Narimatsu, Hiroto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140389/
https://www.ncbi.nlm.nih.gov/pubmed/35627717
http://dx.doi.org/10.3390/ijerph19106182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140389/
https://www.ncbi.nlm.nih.gov/pubmed/35627717
http://dx.doi.org/10.3390/ijerph19106182

Ejemplares similares